Beacon Biosignals, Inc. — Form D
Beacon Biosignals, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-10-04. The offering totals $29.9M, of which $29.9M was reported sold. Industry: Other Technology.
Offering
- Filed: 2021-10-04
- Form: D
- Accession: 0001765647-21-000002
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $29.9M
- Amount sold: $29.9M
- Investors: 42
- Date of first sale: 2021-09-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-415532
Issuer
- Name: Beacon Biosignals, Inc.
- CIK: 0001765647
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 22 Boston Wharf Road Floor 7, BOSTON, MA, 02210
- Phone: 401-225-5782
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Jacob A Donoghue | Director | Boston, MA |
| Naveen A Rao | Director | Boston, MA |
| Jacob A Donoghue | Executive Officer | Boston, MA |
| Jarrett A Revels | Executive Officer | Boston, MA |
| Caitlin Donovan | Related Person | Boston, MA |
| Jacob A Donoghue | Promoter | Boston, MA |
| Jarrett A Revels | Promoter | Boston, MA |
| Naveen Rao | Related Person | Boston, MA |
| Jacob A. Donoghue, M.D., Ph.D. | Related Person | Boston, MA |
| Jarrett Revels | Related Person | Boston, MA |
| Pavel Raifeld | Related Person | Boston, MA |
Other filings by this issuer (2)
More